Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-02-20 @ 1:21 PM
Study NCT ID:
NCT00611793
Status:
COMPLETED
Last Update Posted:
2009-01-23
First Post:
2008-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
Sponsor:
SCRI Development Innovations, LLC
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCRI REFMAL 56
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Howard A. Burris, III, M.D.
Old Organization:
SCRI Oncology Research Consortium
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |